Medical Care
Global Human Microbiome Therapeutics Market Research Report 2024
- Jan 26, 24
- ID: 28871
- Pages: 71
- Figures: 136
- Views: 23
Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Microbiome therapeutics are therapies that are designed to disrupt unhealthy microbial ecological networks and that catalyse the establishment of healthy ones.
The global Human Microbiome Therapeutics market was valued at US$ 965.7 million in 2023 and is anticipated to reach US$ 1590.9 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Microbiome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome Therapeutics.
Report Scope
The Human Microbiome Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Microbiome Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Microbiome Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Enterome Bioscience
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson & Johnson
Takeda Pharmaceutical
Segment by Type
FMT
Microbiome Drugs
Segment by Application
C. difficile
Crohn’s Disease
Inflammatory Bowel Disease
Diabetes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Microbiome Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Human Microbiome Therapeutics market was valued at US$ 965.7 million in 2023 and is anticipated to reach US$ 1590.9 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Microbiome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome Therapeutics.
Report Scope
The Human Microbiome Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Microbiome Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Microbiome Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Enterome Bioscience
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson & Johnson
Takeda Pharmaceutical
Segment by Type
FMT
Microbiome Drugs
Segment by Application
C. difficile
Crohn’s Disease
Inflammatory Bowel Disease
Diabetes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Microbiome Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 FMT
1.2.3 Microbiome Drugs
1.3 Market by Application
1.3.1 Global Human Microbiome Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 C. difficile
1.3.3 Crohn’s Disease
1.3.4 Inflammatory Bowel Disease
1.3.5 Diabetes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Therapeutics Market Perspective (2019-2030)
2.2 Human Microbiome Therapeutics Growth Trends by Region
2.2.1 Global Human Microbiome Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Microbiome Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Human Microbiome Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Human Microbiome Therapeutics Market Dynamics
2.3.1 Human Microbiome Therapeutics Industry Trends
2.3.2 Human Microbiome Therapeutics Market Drivers
2.3.3 Human Microbiome Therapeutics Market Challenges
2.3.4 Human Microbiome Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Therapeutics Players by Revenue
3.1.1 Global Top Human Microbiome Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Human Microbiome Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Human Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Therapeutics Revenue
3.4 Global Human Microbiome Therapeutics Market Concentration Ratio
3.4.1 Global Human Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Therapeutics Revenue in 2023
3.5 Human Microbiome Therapeutics Key Players Head office and Area Served
3.6 Key Players Human Microbiome Therapeutics Product Solution and Service
3.7 Date of Enter into Human Microbiome Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Therapeutics Breakdown Data by Type
4.1 Global Human Microbiome Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Human Microbiome Therapeutics Forecasted Market Size by Type (2025-2030)
5 Human Microbiome Therapeutics Breakdown Data by Application
5.1 Global Human Microbiome Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Human Microbiome Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Microbiome Therapeutics Market Size (2019-2030)
6.2 North America Human Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Microbiome Therapeutics Market Size by Country (2019-2024)
6.4 North America Human Microbiome Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Microbiome Therapeutics Market Size (2019-2030)
7.2 Europe Human Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Microbiome Therapeutics Market Size by Country (2019-2024)
7.4 Europe Human Microbiome Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Human Microbiome Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Microbiome Therapeutics Market Size (2019-2030)
9.2 Latin America Human Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Microbiome Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Human Microbiome Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Human Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Enterome Bioscience
11.1.1 Enterome Bioscience Company Detail
11.1.2 Enterome Bioscience Business Overview
11.1.3 Enterome Bioscience Human Microbiome Therapeutics Introduction
11.1.4 Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.1.5 Enterome Bioscience Recent Development
11.2 Rebiotix
11.2.1 Rebiotix Company Detail
11.2.2 Rebiotix Business Overview
11.2.3 Rebiotix Human Microbiome Therapeutics Introduction
11.2.4 Rebiotix Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.2.5 Rebiotix Recent Development
11.3 Seres Therapeutics
11.3.1 Seres Therapeutics Company Detail
11.3.2 Seres Therapeutics Business Overview
11.3.3 Seres Therapeutics Human Microbiome Therapeutics Introduction
11.3.4 Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.3.5 Seres Therapeutics Recent Development
11.4 Vedanta Biosciences
11.4.1 Vedanta Biosciences Company Detail
11.4.2 Vedanta Biosciences Business Overview
11.4.3 Vedanta Biosciences Human Microbiome Therapeutics Introduction
11.4.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.4.5 Vedanta Biosciences Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Human Microbiome Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Human Microbiome Therapeutics Introduction
11.6.4 Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Detail
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Human Microbiome Therapeutics Introduction
11.7.4 Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.7.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 FMT
1.2.3 Microbiome Drugs
1.3 Market by Application
1.3.1 Global Human Microbiome Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 C. difficile
1.3.3 Crohn’s Disease
1.3.4 Inflammatory Bowel Disease
1.3.5 Diabetes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Therapeutics Market Perspective (2019-2030)
2.2 Human Microbiome Therapeutics Growth Trends by Region
2.2.1 Global Human Microbiome Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Microbiome Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Human Microbiome Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Human Microbiome Therapeutics Market Dynamics
2.3.1 Human Microbiome Therapeutics Industry Trends
2.3.2 Human Microbiome Therapeutics Market Drivers
2.3.3 Human Microbiome Therapeutics Market Challenges
2.3.4 Human Microbiome Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Therapeutics Players by Revenue
3.1.1 Global Top Human Microbiome Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Human Microbiome Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Human Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Therapeutics Revenue
3.4 Global Human Microbiome Therapeutics Market Concentration Ratio
3.4.1 Global Human Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Therapeutics Revenue in 2023
3.5 Human Microbiome Therapeutics Key Players Head office and Area Served
3.6 Key Players Human Microbiome Therapeutics Product Solution and Service
3.7 Date of Enter into Human Microbiome Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Therapeutics Breakdown Data by Type
4.1 Global Human Microbiome Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Human Microbiome Therapeutics Forecasted Market Size by Type (2025-2030)
5 Human Microbiome Therapeutics Breakdown Data by Application
5.1 Global Human Microbiome Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Human Microbiome Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Microbiome Therapeutics Market Size (2019-2030)
6.2 North America Human Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Microbiome Therapeutics Market Size by Country (2019-2024)
6.4 North America Human Microbiome Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Microbiome Therapeutics Market Size (2019-2030)
7.2 Europe Human Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Microbiome Therapeutics Market Size by Country (2019-2024)
7.4 Europe Human Microbiome Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Human Microbiome Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Microbiome Therapeutics Market Size (2019-2030)
9.2 Latin America Human Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Microbiome Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Human Microbiome Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Human Microbiome Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Enterome Bioscience
11.1.1 Enterome Bioscience Company Detail
11.1.2 Enterome Bioscience Business Overview
11.1.3 Enterome Bioscience Human Microbiome Therapeutics Introduction
11.1.4 Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.1.5 Enterome Bioscience Recent Development
11.2 Rebiotix
11.2.1 Rebiotix Company Detail
11.2.2 Rebiotix Business Overview
11.2.3 Rebiotix Human Microbiome Therapeutics Introduction
11.2.4 Rebiotix Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.2.5 Rebiotix Recent Development
11.3 Seres Therapeutics
11.3.1 Seres Therapeutics Company Detail
11.3.2 Seres Therapeutics Business Overview
11.3.3 Seres Therapeutics Human Microbiome Therapeutics Introduction
11.3.4 Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.3.5 Seres Therapeutics Recent Development
11.4 Vedanta Biosciences
11.4.1 Vedanta Biosciences Company Detail
11.4.2 Vedanta Biosciences Business Overview
11.4.3 Vedanta Biosciences Human Microbiome Therapeutics Introduction
11.4.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.4.5 Vedanta Biosciences Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Human Microbiome Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Human Microbiome Therapeutics Introduction
11.6.4 Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Detail
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Human Microbiome Therapeutics Introduction
11.7.4 Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2019-2024)
11.7.5 Takeda Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Human Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of FMT
Table 3. Key Players of Microbiome Drugs
Table 4. Global Human Microbiome Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Human Microbiome Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Microbiome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Human Microbiome Therapeutics Market Share by Region (2019-2024)
Table 8. Global Human Microbiome Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Human Microbiome Therapeutics Market Share by Region (2025-2030)
Table 10. Human Microbiome Therapeutics Market Trends
Table 11. Human Microbiome Therapeutics Market Drivers
Table 12. Human Microbiome Therapeutics Market Challenges
Table 13. Human Microbiome Therapeutics Market Restraints
Table 14. Global Human Microbiome Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Human Microbiome Therapeutics Market Share by Players (2019-2024)
Table 16. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Therapeutics as of 2023)
Table 17. Ranking of Global Top Human Microbiome Therapeutics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Human Microbiome Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Microbiome Therapeutics Product Solution and Service
Table 21. Date of Enter into Human Microbiome Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Human Microbiome Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Human Microbiome Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Human Microbiome Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Human Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Human Microbiome Therapeutics Revenue Market Share by Application (2019-2024)
Table 29. Global Human Microbiome Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Human Microbiome Therapeutics Revenue Market Share by Application (2025-2030)
Table 31. North America Human Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Human Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Human Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Human Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Human Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Human Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Human Microbiome Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Human Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Human Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Human Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Enterome Bioscience Company Detail
Table 47. Enterome Bioscience Business Overview
Table 48. Enterome Bioscience Human Microbiome Therapeutics Product
Table 49. Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 50. Enterome Bioscience Recent Development
Table 51. Rebiotix Company Detail
Table 52. Rebiotix Business Overview
Table 53. Rebiotix Human Microbiome Therapeutics Product
Table 54. Rebiotix Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Rebiotix Recent Development
Table 56. Seres Therapeutics Company Detail
Table 57. Seres Therapeutics Business Overview
Table 58. Seres Therapeutics Human Microbiome Therapeutics Product
Table 59. Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Seres Therapeutics Recent Development
Table 61. Vedanta Biosciences Company Detail
Table 62. Vedanta Biosciences Business Overview
Table 63. Vedanta Biosciences Human Microbiome Therapeutics Product
Table 64. Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Vedanta Biosciences Recent Development
Table 66. Bristol-Myers Squibb Company Detail
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Human Microbiome Therapeutics Product
Table 69. Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. Johnson & Johnson Company Detail
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Human Microbiome Therapeutics Product
Table 74. Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Takeda Pharmaceutical Company Detail
Table 77. Takeda Pharmaceutical Business Overview
Table 78. Takeda Pharmaceutical Human Microbiome Therapeutics Product
Table 79. Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 80. Takeda Pharmaceutical Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Human Microbiome Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. FMT Features
Figure 4. Microbiome Drugs Features
Figure 5. Global Human Microbiome Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Human Microbiome Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. C. difficile Case Studies
Figure 8. Crohn’s Disease Case Studies
Figure 9. Inflammatory Bowel Disease Case Studies
Figure 10. Diabetes Case Studies
Figure 11. Others Case Studies
Figure 12. Human Microbiome Therapeutics Report Years Considered
Figure 13. Global Human Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Human Microbiome Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Human Microbiome Therapeutics Market Share by Region: 2023 VS 2030
Figure 16. Global Human Microbiome Therapeutics Market Share by Players in 2023
Figure 17. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Therapeutics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Human Microbiome Therapeutics Revenue in 2023
Figure 19. North America Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Human Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 21. United States Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Human Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 25. Germany Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Human Microbiome Therapeutics Market Share by Region (2019-2030)
Figure 33. China Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Human Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 41. Mexico Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Human Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 45. Turkey Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Enterome Bioscience Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 48. Rebiotix Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 49. Seres Therapeutics Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 50. Vedanta Biosciences Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 52. Johnson & Johnson Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 53. Takeda Pharmaceutical Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Table 1. Global Human Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of FMT
Table 3. Key Players of Microbiome Drugs
Table 4. Global Human Microbiome Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Human Microbiome Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Microbiome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Human Microbiome Therapeutics Market Share by Region (2019-2024)
Table 8. Global Human Microbiome Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Human Microbiome Therapeutics Market Share by Region (2025-2030)
Table 10. Human Microbiome Therapeutics Market Trends
Table 11. Human Microbiome Therapeutics Market Drivers
Table 12. Human Microbiome Therapeutics Market Challenges
Table 13. Human Microbiome Therapeutics Market Restraints
Table 14. Global Human Microbiome Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Human Microbiome Therapeutics Market Share by Players (2019-2024)
Table 16. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Therapeutics as of 2023)
Table 17. Ranking of Global Top Human Microbiome Therapeutics Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Human Microbiome Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Microbiome Therapeutics Product Solution and Service
Table 21. Date of Enter into Human Microbiome Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Microbiome Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Human Microbiome Therapeutics Revenue Market Share by Type (2019-2024)
Table 25. Global Human Microbiome Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Human Microbiome Therapeutics Revenue Market Share by Type (2025-2030)
Table 27. Global Human Microbiome Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Human Microbiome Therapeutics Revenue Market Share by Application (2019-2024)
Table 29. Global Human Microbiome Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Human Microbiome Therapeutics Revenue Market Share by Application (2025-2030)
Table 31. North America Human Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Human Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Human Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Human Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Human Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Human Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Human Microbiome Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Human Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Human Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Human Microbiome Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Enterome Bioscience Company Detail
Table 47. Enterome Bioscience Business Overview
Table 48. Enterome Bioscience Human Microbiome Therapeutics Product
Table 49. Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 50. Enterome Bioscience Recent Development
Table 51. Rebiotix Company Detail
Table 52. Rebiotix Business Overview
Table 53. Rebiotix Human Microbiome Therapeutics Product
Table 54. Rebiotix Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 55. Rebiotix Recent Development
Table 56. Seres Therapeutics Company Detail
Table 57. Seres Therapeutics Business Overview
Table 58. Seres Therapeutics Human Microbiome Therapeutics Product
Table 59. Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 60. Seres Therapeutics Recent Development
Table 61. Vedanta Biosciences Company Detail
Table 62. Vedanta Biosciences Business Overview
Table 63. Vedanta Biosciences Human Microbiome Therapeutics Product
Table 64. Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 65. Vedanta Biosciences Recent Development
Table 66. Bristol-Myers Squibb Company Detail
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Human Microbiome Therapeutics Product
Table 69. Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. Johnson & Johnson Company Detail
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Human Microbiome Therapeutics Product
Table 74. Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Takeda Pharmaceutical Company Detail
Table 77. Takeda Pharmaceutical Business Overview
Table 78. Takeda Pharmaceutical Human Microbiome Therapeutics Product
Table 79. Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2019-2024) & (US$ Million)
Table 80. Takeda Pharmaceutical Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Human Microbiome Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. FMT Features
Figure 4. Microbiome Drugs Features
Figure 5. Global Human Microbiome Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Human Microbiome Therapeutics Market Share by Application: 2023 VS 2030
Figure 7. C. difficile Case Studies
Figure 8. Crohn’s Disease Case Studies
Figure 9. Inflammatory Bowel Disease Case Studies
Figure 10. Diabetes Case Studies
Figure 11. Others Case Studies
Figure 12. Human Microbiome Therapeutics Report Years Considered
Figure 13. Global Human Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Human Microbiome Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Human Microbiome Therapeutics Market Share by Region: 2023 VS 2030
Figure 16. Global Human Microbiome Therapeutics Market Share by Players in 2023
Figure 17. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Therapeutics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Human Microbiome Therapeutics Revenue in 2023
Figure 19. North America Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Human Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 21. United States Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Human Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 25. Germany Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Human Microbiome Therapeutics Market Share by Region (2019-2030)
Figure 33. China Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Human Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 41. Mexico Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Human Microbiome Therapeutics Market Share by Country (2019-2030)
Figure 45. Turkey Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Human Microbiome Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Enterome Bioscience Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 48. Rebiotix Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 49. Seres Therapeutics Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 50. Vedanta Biosciences Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 52. Johnson & Johnson Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 53. Takeda Pharmaceutical Revenue Growth Rate in Human Microbiome Therapeutics Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232